Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to B-cell Lymphoma
Related studies linked through entity extraction aliases.
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Safety and Efficacy Study of BAFF-R CAR-T Cells in Adult Subjects With CD19-Negative Relapsed or Refractory B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Anti CD19 Gene Therapy for B-cell Lymphoma
- Status
- RECRUITING
- Phase
- NA
CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Study of Multi-targeted CAR-T Therapy in Patients With Relapsed/Refractory B-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Phase 2 Trial of Glofitamab for Minimal Residual Disease in Patients With Large B-cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
- Status
- RECRUITING
- Phase
- PHASE2
Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Find a Suitable Dose of ASP2802 in People With CD20-positive B-cell Lymphomas
- Status
- TERMINATED
- Phase
- PHASE1
CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1